NCT02182583View on ClinicalTrials.gov

Ba253BINEB Compared to Ba253MDI (Metered Dose Inhaler) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE3CompletedINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

October 31, 1998

Primary Completion Date

June 30, 2000

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Ba253MDI

DRUG

Ba253BINEB

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY